IncX4 Plasmid-Mediated

Anti-Bacterial Agents / pharmacology Brazil Drug Resistance, Bacterial / genetics Escherichia coli / drug effects Escherichia coli Proteins / genetics Genomics / methods Humans Microbial Sensitivity Tests / methods Outpatients Plasmids / genetics Polymyxins / pharmacology
CTX-M ESBL bacterial pathogens multidrug-resistant polymyxins

Journal

Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 1 2 2020
medline: 21 8 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

Plasmid-mediated polymyxin resistance has become a global health concern, not only because its dissemination has occurred drastically but also because it has begun to be reported in multidrug-resistant (MDR) pathogens. We hereby report microbiological and genomic characteristics of two

Identifiants

DOI: 10.1089/mdr.2019.0203 PMID: 32004096
pubmed: 32004096
doi: 10.1089/mdr.2019.0203
doi:

Substances chimiques

Anti-Bacterial Agents 0
Escherichia coli Proteins 0
MCR-1 protein, E coli 0
Polymyxins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1326-1333

Auteurs

Caetana P Zamparette (CP)

Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.

Marcos Schorner (M)

Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.

Elizandra Campos (E)

Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.

Quézia Moura (Q)

Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Louise Cerdeira (L)

Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Daniela C Tartari (DC)

Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.

Aline F R Sereia (AFR)

Neoprospecta Microbiome Technologies, Florianopolis, Brazil.

Patricia Cunha (P)

Neoprospecta Microbiome Technologies, Florianopolis, Brazil.

Herrison Fontana (H)

Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Luiz Felipe V de Oliveira (LFV)

Neoprospecta Microbiome Technologies, Florianopolis, Brazil.

Edmundo C Grisard (EC)

Department of Microbiology, Imunology and Parasitology, Biological Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.

Nilton Lincopan (N)

Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Maria Luiza Bazzo (ML)

Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.

Thaís C M Sincero (TCM)

Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › IncX4 Plasmid-Mediated
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Sud › Brésil › IncX4 Plasmid-Mediated
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › IncX4 Plasmid-Mediated
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › IncX4 Plasmid-Mediated
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Protéines Escherichia coli › IncX4 Plasmid-Mediated
questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Biologie › Génétique › Génomique › IncX4 Plasmid-Mediated
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › IncX4 Plasmid-Mediated
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › IncX4 Plasmid-Mediated
questionsmedicales.fr › Personnes › Patients › Patients en consultation externe › IncX4 Plasmid-Mediated
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › IncX4 Plasmid-Mediated
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Perforines › Peptides antimicrobiens cationiques › Polymyxines › IncX4 Plasmid-Mediated